Please direct all media inquiries to Gina Cella at gcella@ataaction.org or 781-799-3137
Press Release
ATA ACTION PROVIDES INITIAL REACTION TO DEA PROPOSED RULE ON SPECIAL REGISTRATIONS FOR TELEMEDICINE AND LIMITED STATE TELEMEDICINE REGISTRATIONS
WASHINGTON, D.C., JANUARY 15, 2025 – ATA Action provides initial response to the Special Registration for Telemedicine framework published this morning by the Drug Enforcement Administration (DEA) authorizing certain DEA-registered practitioners to engage in the...
ATA ACTION CALLS FOR DEA TO ESTABLISH A WORKGROUP TO CREATE PERMANENT FRAMEWORK FOR REMOTE PRESCRIBING OF CONTROLLED SUBSTANCES
WASHINGTON, D.C., JANUARY 14, 2025 – This morning, ATA Action urged the Drug Enforcement Agency (DEA) to take immediate steps to form a public-private workgroup to establish a permanent framework for the remote prescribing of controlled substances. In a letter to DEA...
ATA ACTION LETTER TO CONGRESSIONAL LEADERSHIP OUTLINES TELEHEALTH PRIORITIES FOR 119TH CONGRESS
WASHINGTON, D.C., JANUARY 13, 2025 – With critical telehealth flexibilities set to expire on March 31, 2025, and key provisions already lapsed as of December 31, 2024, urgent action is needed to prevent millions of patients from losing access to essential virtual care...